Circadian rhythms in diabetic retinopathy: an overview of pathogenesis and investigational drugs

References

• Bass J, Takahashi JS. Circadian integration of metabolism and energetics. Science. 2010Dec3;330(6009):1349–1354. .
   PubMed Web of Science ®Google Scholar
• Duffy JF, Zitting KM, Chinoy ED, Aging and Circadian Rhythms. Sleep Med Clin. 2015 Dec; 10(4):423–434
   PubMed Web of Science ®Google Scholar
• Vitaterna MH, Takahashi JS, Turek FW. Overview of circadian rhythms. Alcohol Res Health. 2001;25(2):85–93.
   PubMedGoogle Scholar
• Czeisler CA, Duffy JF, Shanahan TL, et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science. 1999 Jun 25;284(5423):2177–2181.
   PubMed Web of Science ®Google Scholar
• Mistlberger RE, Skene DJ. Social influences on mammalian circadian rhythms: animal and human studies. Biol Rev. 2004;79(3):533–556.
   PubMed Web of Science ®Google Scholar
• Emens JS, Burgess HJ. Effect of light and melatonin and other melatonin receptor agonists on human circadian physiology. Sleep Med Clin. 2015 Dec;10(4):435–453.
   PubMed Web of Science ®Google Scholar
• Reid KJ. Assessment of Circadian Rhythms. Neurol Clin. 2019 Aug;37(3):505–526.
   PubMed Web of Science ®Google Scholar
• Patton AP, Hastings MH. The suprachiasmatic nucleus. Curr Biol. 2018 Aug 6;28(15):R816–r822.
   PubMed Web of Science ®Google Scholar
• Hastings MH, Maywood ES, Brancaccio M. Generation of circadian rhythms in the suprachiasmatic nucleus. Nat Rev Neurosci. 2018 Aug;19(8):453–469.
   PubMed Web of Science ®Google Scholar
• Weaver DR. The suprachiasmatic nucleus: a 25-year retrospective. J Biol Rhythms. 1998 Apr;13(2):100–112.
   PubMed Web of Science ®Google Scholar
• Colwell CS. Linking neural activity and molecular oscillations in the SCN. Nat Rev Neurosci. 2011 Sep 2;12(10):553–569.
   PubMed Web of Science ®Google Scholar
• Morin LP, Allen CN. The circadian visual system, 2005. Brain Res Rev. 2006 Jun;51(1):1–60.
   PubMedGoogle Scholar
• Wässle H. Parallel processing in the mammalian retina. Nat Rev Neurosci. 2004;5(10):747–757.
   PubMed Web of Science ®Google Scholar
• Ruan G-X, Zhang D-Q, Zhou T, et al. Circadian organization of the mammalian retina. Proc Nat Acad Sci. 2006;103(25):9703–9708.
   PubMed Web of Science ®Google Scholar
• Tosini G, Davidson AJ, Fukuhara C, et al. Localization of a circadian clock in mammalian photoreceptors. Faseb J. 2007;21(14):3866–3871.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang Z, Ribelayga CP. Heterogeneous expression of the core circadian clock proteins among neuronal cell types in mouse retina. PloS One. 2012;7(11):e50602.
   PubMed Web of Science ®Google Scholar
• Lee HS, Nelms JL, Nguyen M, et al. The eye is necessary for a circadian rhythm in the suprachiasmatic nucleus. Nat Neurosci. 2003;6(2):111–112.
   PubMed Web of Science ®Google Scholar
• Álvarez-López C, Cernuda-Cernuda R, Alcorta E, et al. Altered endogenous activation of CREB in the suprachiasmatic nucleus of mice with retinal degeneration. Brain Res. 2004;1024(1–2):137–145.
   PubMed Web of Science ®Google Scholar
• Storch K-F, Paz C, Signorovitch J, et al. Intrinsic circadian clock of the mammalian retina: importance for retinal processing of visual information. Cell. 2007;130(4):730–741.
   PubMed Web of Science ®Google Scholar
• Sawant OB, Horton AM, Zucaro OF, et al. The circadian clock gene Bmal1 controls thyroid hormone-mediated spectral identity and cone photoreceptor function. Cell Rep. 2017;21(3):692–706.
   PubMed Web of Science ®Google Scholar
• Baba K, Piano I, Lyuboslavsky P, et al. Removal of clock gene Bmal1 from the retina affects retinal development and accelerates cone photoreceptor degeneration during aging. Proc Nat Acad Sci. 2018;115(51):13099–13104.
   PubMed Web of Science ®Google Scholar
• Bhatwadekar AD, Beli E, Diao Y, et al. Conditional deletion of Bmal1 accentuates microvascular and macrovascular injury. Am J Pathol. 2017;187(6):1426–1435.
   PubMed Web of Science ®Google Scholar
• Ait‐Hmyed O, Felder‐Schmittbuhl MP, Garcia‐Garrido M, et al. Mice lacking Period 1 and Period 2 circadian clock genes exhibit blue cone photoreceptor defects. Eur J Neurosci. 2013;37(7):1048–1060.
   PubMed Web of Science ®Google Scholar
• Ait‐Hmyed Hakkari O, Acar N, Savier E, et al. Rev‐Erbα modulates retinal visual processing and behavioral responses to light. Faseb J. 2016;30(11):3690–3701.
   PubMed Web of Science ®Google Scholar
• Wong JC, Smyllie NJ, Banks GT, et al. Differential roles for cryptochromes in the mammalian retinal clock. Faseb J. 2018;32(8):4302–4314.
   PubMed Web of Science ®Google Scholar
• Tosini G, Menaker M. Circadian rhythms in cultured mammalian retina. Science. 1996;272(5260):419–421.
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Oishi K, Shiraishi M, et al. Two circadian oscillatory mechanisms in the mammalian retina. Neuroreport. 2000;11(18):3995–3997.
   PubMed Web of Science ®Google Scholar
• Chen W, Baler R. The rat arylalkylamine N-acetyltransferase E-box: differential use in a master vs. a slave oscillator. Mol Brain Res. 2000;81(1–2):43–50.
   PubMedGoogle Scholar
• Bonmati-Carrion MA, Arguelles-Prieto R, Martinez-Madrid MJ, et al. Protecting the melatonin rhythm through circadian healthy light exposure. Int J Mol Sci. 2014;15(12):23448–23500.
   PubMed Web of Science ®Google Scholar
• Daneault V, Dumont M, Masse E, et al. Light-sensitive brain pathways and aging. J Physiol Anthropol. 2016;35(1):1–12.
   PubMedGoogle Scholar
• Sengupta A, Baba K, Mazzoni F, et al. Localization of melatonin receptor 1 in mouse retina and its role in the circadian regulation of the electroretinogram and dopamine levels. PloS One. 2011;6(9):e24483.
   PubMed Web of Science ®Google Scholar
• Wiechmann AF, Summers JA. Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues. Prog Retin Eye Res. 2008;27(2):137–160.
   PubMed Web of Science ®Google Scholar
• Savaskan E, Wirz-Justice A, Olivieri G, et al. Distribution of melatonin MT1 receptor immunoreactivity in human retina. J Histochem Cytochem. 2002;50(4):519–525.
   PubMed Web of Science ®Google Scholar
• Savaskan E, Jockers R, Ayoub M, et al. The MT2 melatonin receptor subtype is present in human retina and decreases in Alzheimer’s disease. Curr Alzheimer Res. 2007 Feb;4(1):47–51.
   PubMed Web of Science ®Google Scholar
• Diabetes facts 2020. [cited 2020 Jun]. Available from: https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html
   Google Scholar
• International Diabetes Federation - Eye health 2020.  [cited 2020 Jun]. Available from: https://www.idf.org/our-activities/care-prevention/eye-health.html
   Google Scholar
• Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260–277.
   PubMed Web of Science ®Google Scholar
• Kusuhara S, Fukushima Y, Ogura S, et al. Pathophysiology of diabetic retinopathy: the old and the new. Diabetes Metab J. 2018;42(5):364–376.
   PubMed Web of Science ®Google Scholar
• Kwon J-W, Jee D, La TY. Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy. Medicine (Baltimore). 2017;96:10.
   Web of Science ®Google Scholar
• Havens SJ, Gulati V. Neovascular glaucoma. Retinal pharmacotherapeutics. Vol. 55.  Basel, Switzerland: Karger Publishers; 2016. p. 196–204.
   Google Scholar
• Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest. 1996;97(12):2883–2890.
   PubMed Web of Science ®Google Scholar
• Stefánsson E, Chan YK, Bek T, et al. Laws of physics help explain capillary non-perfusion in diabetic retinopathy. Eye. 2018;32(2):210–212.
   PubMed Web of Science ®Google Scholar
• Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight. 2017;2:14.
   Web of Science ®Google Scholar
• Shin ES, Sorenson CM, Sheibani N. Diabetes and retinal vascular dysfunction. J Ophthalmic Vis Res. 2014;9(3):362.
   PubMedGoogle Scholar
• Barber AJ, Lieth E, Khin SA, et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest. 1998;102(4):783–791.
   PubMed Web of Science ®Google Scholar
• Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012 Mar 29; 366(13):1227–1239.
   PubMed Web of Science ®Google Scholar
• Gao G, Li Y, Zhang D, et al. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 2001;489(2–3):270–276.
   PubMed Web of Science ®Google Scholar
• Kolár P. Patophysiology of diabetic retinopathy. Vnitr Lek. 2013;59(3):173.
   PubMedGoogle Scholar
• West KE, Jablonski MR, Warfield B, et al. Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans. J Appl Physiol. 2011;110(3):619-626.
   Web of Science ®Google Scholar
• Publishing HH. Blue light has a dark side - Harvard Health. 2020. [cited 2020 Jun]. Available from: https://www.health.harvard.edu/staying-healthy/blue-light-has-a-dark-side
   Google Scholar
• Busik JV, Tikhonenko M, Bhatwadekar A, et al. Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med. 2009;206(13):2897–2906.
   PubMed Web of Science ®Google Scholar
• Polito A, Del Borrello M, Polini G, et al. Diurnal variation in clinically significant diabetic macular edema measured by the stratus OCT. Retina. 2006;26(1):14–20.
   PubMed Web of Science ®Google Scholar
• Kotsidis ST, Lake SS, Alexandridis AD, et al. 24-Hour variation of optical coherence tomography–measured retinal thickness in diabetic macular edema. Eur J Ophthalmol. 2012;22(5):785–791.
   PubMed Web of Science ®Google Scholar
• Larsen M, Wang M, Sander B. Overnight thickness variation in diabetic macular edema. Invest Ophthalmol Vis Sci. 2005;46(7):2313–2316.
   PubMed Web of Science ®Google Scholar
• Dost A, Bechtold‐Dalla Pozza S, Bollow E, et al. Blood pressure regulation determined by ambulatory blood pressure profiles in children and adolescents with type 1 diabetes mellitus: impact on diabetic complications. Pediatr Diabetes. 2017;18(8):874–882.
   PubMed Web of Science ®Google Scholar
• Alio J, Hernandez I, Millan A, et al. Pupil responsiveness in diabetes mellitus. Ann Ophthalmol. 1989;21(4):132–137.
   PubMedGoogle Scholar
• Fulk GW, Bower A, McBRIDE K, et al. Sympathetic denervation of the iris dilator in noninsulin-dependent diabetes. Optometry Vision Sci. 1991;68(12):954–956.
   PubMed Web of Science ®Google Scholar
• Lucas R, Hattar S, Takao M, et al. Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice. Science. 2003;299(5604):245–247.
   PubMed Web of Science ®Google Scholar
• Park JC, Chen Y-F, Blair NP, et al. Pupillary responses in non-proliferative diabetic retinopathy. Sci Rep. 2017;7:44987.
   PubMed Web of Science ®Google Scholar
• Ba‐Ali S, Brøndsted AE, Andersen HU, et al. Pupillary light responses in type 1 and type 2 diabetics with and without retinopathy. Acta Ophthalmol. 2020;98(5): 477-484.
   Web of Science ®Google Scholar
• Poulsen P, Bek T, Ebbehøj E, et al. 24-h ambulatory blood pressure and retinopathy in normoalbuminuric IDDM patients. Diabetologia. 1998;41(1):105–110.
   PubMed Web of Science ®Google Scholar
• Mateo-Gavira I, Vílchez-López FJ, García-Palacios MV, et al. Nocturnal blood pressure is associated with the progression of microvascular complications and hypertension in patients with type 1 diabetes mellitus. J Diabetes Complications. 2016;30(7):1326–1332.
   PubMed Web of Science ®Google Scholar
• Knudsen ST, Poulsen PL, Hansen KW, et al. Pulse pressure and diurnal blood pressure variation: association with micro-and macrovascular complications in type 2 diabetes. Am J Hypertens. 2002;15(3):244–250.
   PubMed Web of Science ®Google Scholar
• Ba-Ali S, Brøndsted AE, Andersen HU, et al. Assessment of diurnal melatonin, cortisol, activity, and sleep− wake cycle in patients with and without diabetic retinopathy. Sleep Med. 2019;54:35–42.
   PubMed Web of Science ®Google Scholar
• Reutrakul S, Crowley SJ, Park JC, et al. Relationship between intrinsically photosensitive ganglion cell function and circadian regulation in diabetic retinopathy. Sci Rep. 2020;10(1):1–11.
   PubMed Web of Science ®Google Scholar
• Hikichi T, Tateda N, Miura T. Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy. Clin Ophthalmol. 2011;5:655.
   PubMedGoogle Scholar
• Chen W, Cao H, Lu Q-Y, et al. Urinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes. Int J Clin Exp Pathol. 2014;7(7):4317.
   PubMed Web of Science ®Google Scholar
• Reutrakul S, Siwasaranond N, Nimitphong H, et al. Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes. Chronobiol Int. 2017;34(3):382–392.
   PubMed Web of Science ®Google Scholar
• Aydin E, Sahin S. Increased melatonin levels in aqueous humor of patients with proliferative retinopathy in type 2 diabetes mellitus. Int J Ophthalmol. 2016;9(5):721.
   PubMed Web of Science ®Google Scholar
• Ames A, Li -Y-Y, Heher E, et al. Energy metabolism of rabbit retina as related to function: high cost of Na+ transport. J Neurosci. 1992;12(3):840–853.
   PubMed Web of Science ®Google Scholar
• Tyni T, Paetau A, Strauss AW, et al. Mitochondrial fatty acid β-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res. 2004;56(5):744–750.
   PubMed Web of Science ®Google Scholar
• Vancura P, Wolloscheck T, Baba K, et al. Circadian and dopaminergic regulation of fatty acid oxidation pathway genes in retina and photoreceptor cells. PLoS One. 2016;11(10):e0164665.
   PubMed Web of Science ®Google Scholar
• Tikhonenko M, Lydic TA, Wang Y, et al. Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes. 2010;59(1):219–227.
   PubMed Web of Science ®Google Scholar
• Wang Q, Tikhonenko M, Bozack SN, et al. Changes in the daily rhythm of lipid metabolism in the diabetic retina. PloS One. 2014;9(4):e95028.
   PubMed Web of Science ®Google Scholar
• Obara EA, Hannibal J, Heegaard S, et al. Loss of melanopsin-expressing retinal ganglion cells in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58(4):2187–2192.
   PubMed Web of Science ®Google Scholar
• Bhatwadekar AD, Yan Y, Qi X, et al. Per2 mutation recapitulates the vascular phenotype of diabetes in the retina and bone marrow. Diabetes. 2013;62(1):273–282.
   PubMed Web of Science ®Google Scholar
• Jadhav V, Luo Q, Dominguez M, et al. Per2-mediated vascular dysfunction is caused by the upregulation of the connective tissue growth factor (CTGF). PloS One. 2016;11(9):e0163367.
   PubMed Web of Science ®Google Scholar
• Coughlin BA, Feenstra DJ, Mohr S. Müller cells and diabetic retinopathy. Vision Res. 2017;139:93–100.
   PubMed Web of Science ®Google Scholar
• Pannicke T, Iandiev I, Wurm A, et al. Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina. Diabetes. 2006;55(3):633–639.
   PubMed Web of Science ®Google Scholar
• Hassan I, Luo Q, Majumdar S, et al. Tumor necrosis factor alpha (TNF-α) disrupts Kir4. 1 channel expression resulting in müller cell dysfunction in the retina. Invest Ophthalmol Vis Sci. 2017;58(5):2473–2482.
   PubMed Web of Science ®Google Scholar
• Alex A, Luo Q, Mathew D, et al. Metformin corrects abnormal circadian rhythm and kir4.1 channels in diabetes. Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):46.
   PubMed Web of Science ®Google Scholar
• Wang Q, Bozack SN, Yan Y, et al. Regulation of retinal inflammation by rhythmic expression of MiR-146a in diabetic retina. Invest Ophthalmol Vis Sci. 2014;55(6):3986–3994.
   PubMed Web of Science ®Google Scholar
• Qi X, Mitter SK, Yan Y, et al. Diurnal rhythmicity of autophagy is impaired in the diabetic retina. Cells. 2020;9(4):905.
   PubMed Web of Science ®Google Scholar
• Bughi S, Shaw S, Bessman A. Laser damage to retinal ganglion cells: the effect on circadian rhythms. J Diabetes Complications. 2006;20(3):184–187.
   PubMed Web of Science ®Google Scholar
• Do Carmo Buonfiglio D, Peliciari-Garcia RA, Do Amaral FG, et al. Early-stage retinal melatonin synthesis impairment in streptozotocin-induced diabetic wistar rats. Invest Ophthalmol Vis Sci. 2011;52(10):7416–7422.
   PubMed Web of Science ®Google Scholar
• Mehrzadi S, Motevalian M, Rezaei Kanavi M, et al. Protective effect of melatonin in the diabetic rat retina. Fundam Clin Pharmacol. 2018;32(4):414–421.
   PubMed Web of Science ®Google Scholar
• Jiang T, Chang Q, Cai J, et al. Protective effects of melatonin on retinal inflammation and oxidative stress in experimental diabetic retinopathy. Oxid Med Cell Longev. 2016;2016.
   Web of Science ®Google Scholar
• Djordjevic B, Cvetkovic T, Stoimenov TJ, et al. Oral supplementation with melatonin reduces oxidative damage and concentrations of inducible nitric oxide synthase, VEGF and matrix metalloproteinase 9 in the retina of rats with streptozotocin/nicotinamide induced pre-diabetes. Eur J Pharmacol. 2018;833:290–297.
   PubMed Web of Science ®Google Scholar
• Jiang T, Chang Q, Zhao Z, et al. Melatonin-mediated cytoprotection against hyperglycemic injury in müller cells. PLoS One. 2012;7(12):e50661.
   PubMed Web of Science ®Google Scholar
• Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm - Full Text View - ClinicalTrials.gov 2020. [cited 2020 Jun]. Available from: https://clinicaltrials.gov/ct2/show/NCT03478306
   Google Scholar
• Liu J, Clough SJ, Hutchinson AJ, et al. MT1 and MT2 melatonin receptors: a therapeutic perspective. Annu Rev Pharmacol Toxicol. 2016;56:361–383.
   PubMed Web of Science ®Google Scholar
• Lockley SW, Dressman MA, Licamele L, et al. Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials. Lancet. 2015;386(10005):1754–1764.
   PubMed Web of Science ®Google Scholar
• Quera Salva MA, Hartley S, Léger D, et al. Non-24-hour sleep–wake rhythm disorder in the totally blind: diagnosis and management. Front Neurol. 2017;8:686.
   PubMed Web of Science ®Google Scholar
• Barnea M, Haviv L, Gutman R, et al. Metformin affects the circadian clock and metabolic rhythms in a tissue-specific manner. Biochim Biophys Acta Mol Basis Dis. 2012;1822(11):1796–1806.
   PubMed Web of Science ®Google Scholar
• Lamia KA, Sachdeva UM, DiTacchio L, et al. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science. 2009;326(5951):437–440.
   PubMed Web of Science ®Google Scholar
• Vieira E. The impact of metformin on circadian clock gene. J Diabetes Metab Disord Control. 2014;1(3):00016.
   Google Scholar
• Thomas AP, Hoang J, Vongbunyong K, et al. Administration of melatonin and metformin prevents deleterious effects of circadian disruption and obesity in male rats. Endocrinology. 2016;157(12):4720–4731.
   PubMed Web of Science ®Google Scholar
• Diabetes. 2020. [cited 2020 Jun]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
   Google Scholar
• Ciulla TA, Bracha P, Pollack J, et al. Real-world outcomes of anti–vascular endothelial growth factor therapy in diabetic macular edema in the United States. Ophthalmol Retina. 2018;2(12):1179–1187.
   PubMedGoogle Scholar
• Ciulla TA, Hussain RM, Pollack JS, et al. Visual acuity outcomes and anti–vascular endothelial growth factor therapy intensity in neovascular age-related macular degeneration patients: a real-world analysis of 49 485 eyes. Ophthalmol Retina. 2020;4(1):19–30.
   PubMedGoogle Scholar
• Miller BH, McDearmon EL, Panda S, et al. Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3342–3347.
   PubMed Web of Science ®Google Scholar
• The Nobel Prize in Physiology or Medicine 2017 2020. [cited 2020 Jun]. Available from: https://www.nobelprize.org/prizes/medicine/2017/press-release/
   Google Scholar
• Montaigne D, Marechal X, Modine T, et al. Daytime variation of perioperative myocardial injury in cardiac surgery and its prevention by Rev-Erbα antagonism: a single-centre propensity-matched cohort study and a randomised study. Lancet. 2018;391(10115):59–69.
   PubMed Web of Science ®Google Scholar
• Koyanagi S, Kuramoto Y, Nakagawa H, et al. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res. 2003;63(21):7277–7283.
   PubMed Web of Science ®Google Scholar
• Cha HK, Chung S, Lim HY, et al. Small molecule modulators of the circadian molecular clock with implications for neuropsychiatric diseases. Front Mol Neurosci. 2019;11:496.
   PubMed Web of Science ®Google Scholar